WebApr 7, 2024 · GILD opened at $83.37 on Friday. Gilead Sciences, Inc. has a fifty-two week low of $57.17 and a fifty-two week high of $89.74. The business has a 50-day moving average of $82.11 and a 200-day moving average of $79.98. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.29 and a quick ratio of 1.15. WebBased on 14 Wall Street analysts offering 12 month price targets for Pfizer in the last 3 months. The average price target is $48.43 with a high forecast of $75.00 and a low forecast of $40.00. The average price target represents a 16.70% change from the last price of $41.50. Highest Price Target $75.00. Average Price Target $48.43.
Barrick Gold Corporation (GOLD) Stock Forecast, Price Targets and ...
Web2 days ago · The high end of $26.5 billion for 2024 points to a 1.8% decline from last year (Table 1) and is currently below analyst expectations by $220 million. Excluding Veklury, $24.5 billion represents a ... WebApr 6, 2024 · Future criteria checks 0/6. Gilead Sciences is forecasted to grow earnings and revenue by 7.6% and 1.9% per annum respectively. EPS and ROE are also expected to … lvb leipzig tarifzone 110
GILD - Gilead Sciences Inc Stock quote - CNNMoney.com
WebWall Street analysts forecast GILD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GILD is 90.74 USD with a low … Web2 days ago · Gilead Sciences Inc. analyst estimates, including GILD earnings per share estimates and analyst recommendations. ... Stock Price Targets. High: $115.00: Median: $90.00: Low: $77.00: Average: $90. ... WebApr 12, 2024 · Natixis Advisors L.P.'s holdings in Gilead Sciences were worth $16,750,000 at the end of the most recent reporting period. Several other hedge funds also recently bought and sold shares of GILD. JFS Wealth Advisors LLC increased its position in Gilead Sciences by 68.1% during the third quarter. JFS Wealth Advisors LLC now owns 400 … lvb medical abbreviation